Your browser doesn't support javascript.
loading
How likely is the sense-B-noise to affect patients with subcutaneous implantable cardioverter-defibrillators and can we solve that problem in every case?
Budrejko, Szymon; Zienciuk-Krajka, Agnieszka; Oledzki, Szymon; Danilowicz-Szymanowicz, Ludmila; Kempa, Maciej.
Afiliação
  • Budrejko S; Department of Cardiology and Electrotherapy, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
  • Zienciuk-Krajka A; Department of Cardiology and Electrotherapy, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
  • Oledzki S; Department of Cardiology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Danilowicz-Szymanowicz L; Department of Cardiology and Electrotherapy, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
  • Kempa M; Department of Cardiology and Electrotherapy, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Pacing Clin Electrophysiol ; 46(12): 1472-1477, 2023 12.
Article em En | MEDLINE | ID: mdl-37864812
ABSTRACT

BACKGROUND:

Sense-B-noise is a newly reported possible cause of inappropriate shocks in patients with subcutaneous implantable cardioverter-defibrillators (S-ICDs). The nature of that noise is unknown, it is not related to mechanical failure of the S-ICD system. Reprogramming to the secondary sensing vector is suggested by the producer as a possible solution.

METHODS:

We analyzed the medical records of S-ICD recipients from two university clinical centers (Gdansk and Szczecin, Poland). Our aim was to determine the rate of sense-B-noise, and whether the secondary sensing vector would be available for reprogramming if such a problem occurred in our patients.

RESULTS:

The sense-B-noise issue affected three patients in our cohort (3%), which corresponds to the incidence of 0.012 events per patient-year of follow-up. The primary vector was permanently used in 47 patients (52%), secondary in 28 (31%), and alternate in 16 (17%), respectively. Therefore, the total number of patients potentially vulnerable to sense-B noise (with the primary or alternate vector programmed permanently) was 63 (69%). Among those 63 patients, 51 individuals (81%) had also the secondary vector available for permanent use.

CONCLUSION:

The sense-B-noise affected 3% of patients in our cohort, with an incidence of 0.012 per patient-year of follow-up. Most patients potentially vulnerable to sense-B noise could be reprogrammed to the secondary sensing vector, if necessary. Further investigation of the sense-B-noise issue is needed.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Desfibriladores Implantáveis Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Pacing Clin Electrophysiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Desfibriladores Implantáveis Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Pacing Clin Electrophysiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia